首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Withdrawing FDA Approval of Midodrine After Marketing
被引:2
|
作者
:
Holtzman, Neil A.
论文数:
0
引用数:
0
h-index:
0
机构:
Johns Hopkins Med Inst, Baltimore, MD 21205 USA
Johns Hopkins Med Inst, Baltimore, MD 21205 USA
Holtzman, Neil A.
[
1
]
Starfield, Barbara
论文数:
0
引用数:
0
h-index:
0
机构:
Johns Hopkins Med Inst, Baltimore, MD 21205 USA
Johns Hopkins Med Inst, Baltimore, MD 21205 USA
Starfield, Barbara
[
1
]
机构
:
[1]
Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源
:
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2011年
/ 305卷
/ 08期
关键词
:
D O I
:
10.1001/jama.2011.161
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:781 / 782
页数:2
相关论文
共 50 条
[21]
FDA Approval for Vectical
不详
论文数:
0
引用数:
0
h-index:
0
不详
[J].
JOURNAL OF DRUGS IN DERMATOLOGY,
2009,
8
(05)
: 497
-
497
[22]
FDA APPROVAL IS NOT A SHIELD
Hess, Glenn
论文数:
0
引用数:
0
h-index:
0
Hess, Glenn
[J].
CHEMICAL & ENGINEERING NEWS,
2010,
88
(23)
: 12
-
12
[23]
FDA Approval: Blinatumomab
Przepiorka, Donna
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Przepiorka, Donna
Ko, Chia-Wen
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Ko, Chia-Wen
Deisseroth, Albert
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Deisseroth, Albert
Yancey, Carolyn L.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Yancey, Carolyn L.
Candau-Chacon, Reyes
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Candau-Chacon, Reyes
Chiu, Haw-Jyh
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Chiu, Haw-Jyh
Gehrke, Brenda J.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Gehrke, Brenda J.
Gomez-Broughton, Candace
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Gomez-Broughton, Candace
Kane, Robert C.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Kane, Robert C.
Kirshner, Susan
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Kirshner, Susan
Mehrotra, Nitin
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Mehrotra, Nitin
Ricks, Tiffany K.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Ricks, Tiffany K.
Schmiel, Deborah
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Schmiel, Deborah
Song, Pengfei
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Song, Pengfei
Zhao, Ping
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Zhao, Ping
Zhou, Qing
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Zhou, Qing
Farrell, Ann T.
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Farrell, Ann T.
Pazdur, Richard
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
Pazdur, Richard
[J].
CLINICAL CANCER RESEARCH,
2015,
21
(18)
: 4035
-
4039
[24]
FDA and drug approval
Faich, GA
论文数:
0
引用数:
0
h-index:
0
Faich, GA
[J].
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY,
1995,
6
(06)
: S24
-
S24
[25]
FDA Approval of Ipilimumab
不详
论文数:
0
引用数:
0
h-index:
0
不详
[J].
JOURNAL OF DRUGS IN DERMATOLOGY,
2011,
10
(05)
: 552
-
552
[26]
FDA ALENDRONATE APPROVAL
MCCARTHY, M
论文数:
0
引用数:
0
h-index:
0
MCCARTHY, M
[J].
LANCET,
1995,
346
(8981):
: 1028
-
1028
[27]
FDA Approval for Golimumab
不详
论文数:
0
引用数:
0
h-index:
0
不详
[J].
JOURNAL OF DRUGS IN DERMATOLOGY,
2009,
8
(08)
: 777
-
777
[28]
FDA Approval for Rectiv
不详
论文数:
0
引用数:
0
h-index:
0
不详
[J].
JOURNAL OF DRUGS IN DERMATOLOGY,
2011,
10
(08)
: 939
-
939
[29]
THE FDA APPROVAL PROCESS
HOKE, F
论文数:
0
引用数:
0
h-index:
0
HOKE, F
[J].
SCIENTIST,
1994,
8
(18):
: 6
-
6
[30]
FDA approval likely
不详
论文数:
0
引用数:
0
h-index:
0
不详
[J].
EUROPEAN CHEMICAL NEWS,
1996,
66
(1741):
: 52
-
52
←
1
2
3
4
5
→